Thyroid Nodule on Ultrasound: What Happens Next?

The American Thyroid Association defines a thyroid nodule simply as a discrete lesion within the thyroid gland. Ultrasound can detect lesions as small as 2 mm, which is one reason nodules turn up so often.

Most thyroid nodules are benign. The purpose of the workup is not to biopsy everything. It is to sort the small number that need tissue from the large number that do not, and to avoid operations on lumps that would never have caused harm.

In every person with a thyroid nodule, TSH (thyroid-stimulating hormone) should be measured first, and the result steers everything after it.

A normal or high TSH raises concern, because the risk of a cancer rises in parallel with the TSH level. These nodules go on to ultrasound assessment and possible biopsy.

A low TSH usually favors a benign nodule. The next step is different: a scan using iodine-123 or pertechnetate to look for an autonomously functioning nodule, meaning one making thyroid hormone on its own. These "hot" nodules are usually benign and rarely need further diagnostic work.

That fork in the road is why a low TSH can spare you a needle entirely.

Certain ultrasound features have been identified as independent risk factors for cancer:

• Microcalcifications, tiny bright specks inside the nodule.
• Irregular margins, meaning a ragged rather than smooth edge.
• Hypoechogenicity, meaning the nodule appears darker than the surrounding thyroid.
• A taller-than-wide shape on the cross-section view.
• Increased blood flow within the nodule.

Physical examination adds to this. Concerning findings include a nodule over 4 cm, which carries roughly a 19 percent risk of cancer, firmness, fixation to nearby tissue, enlarged neck lymph nodes, and vocal cord paralysis. The combination of a solitary nodule, cervical lymph nodes larger than 1 cm, and vocal cord paralysis has a positive predictive value of close to 100 percent for a thyroid cancer.

The ACR TI-RADS system assigns points across five categories and adds them up.

Composition. Cystic or spongiform scores 0. Mixed cystic and solid scores 1. Solid or almost completely solid scores 2. If composition cannot be determined, classify it as solid.

Echogenicity of the solid part. Hyperechoic or isoechoic scores 1. Hypoechoic scores 2. Very hypoechoic scores 3. If echogenicity cannot be determined, classify it as isoechoic.

Additional features, each adding points. Macrocalcifications add 1. Peripheral rim calcifications add 2. Punctate echogenic foci add 3. A lobulated or irregular margin without spread outside the thyroid adds 2. A taller-than-wide shape adds 3. Definite extension outside the thyroid adds 3.

The total gives a TI-RADS level, and each level pairs a biopsy threshold with a follow-up threshold:

• TR1, 0 points: no biopsy, no follow-up.
• TR2, 2 points: no biopsy, no follow-up.
• TR3, 3 points: biopsy if 2.5 cm or larger. Follow if 1.5 cm or larger. Nothing if under 1.5 cm.
• TR4, 4 to 6 points: biopsy if 1.5 cm or larger. Follow if 1.0 cm or larger. Nothing if under 1.0 cm.
• TR5, over 6 points: biopsy if 1.0 cm or larger. Follow if 0.5 cm or larger. Nothing if under 0.5 cm.

Nodules with definite extension outside the thyroid should be treated as cancer until proven otherwise.

Two things follow from that table. First, size alone never decides. A 2 cm TR2 nodule needs nothing, while a 1.2 cm TR5 nodule needs a needle. Second, "no biopsy and no follow-up" is a real, guideline-supported answer, not a brush-off.

If the recommendation is surveillance, ask for specifics rather than a vague "we will keep an eye on it." Useful questions are: what interval, what measurement counts as growth, and who will order the next scan.

Repeat scans should ideally be at the same center, because measurement varies between operators, and a difference of a few millimeters between machines is easy to mistake for growth.

Many nodules turn up on a CT, MRI, or PET done for something else. Most are unimportant, with one clear exception.

Among incidental thyroid nodules in people already diagnosed with a non-thyroid cancer, one study found a 24 percent rate of malignancy. If you have a known cancer elsewhere and a thyroid nodule appears on staging imaging, that is a nodule to pursue rather than dismiss.

A single nodule carries a higher chance of cancer than any one nodule inside a multinodular gland. But the overall risk for the person is roughly equal, because the risk of each nodule adds up in a gland full of them.

So a report saying "multinodular goiter" is not automatically reassuring. What matters is whether any individual nodule has concerning features.

Fine-needle aspiration is the cornerstone of thyroid nodule evaluation and the most cost-effective test available.

One point is worth insisting on. Ultrasound-guided FNA is preferred over biopsy guided by feel alone, which has higher rates of false-negative results and of samples that cannot be read. If you are offered a palpation-guided biopsy, ask whether ultrasound guidance is available.

The cytology result comes back as a Bethesda category, which has its own risk scale and its own next steps.

Most people with papillary thyroid cancer, the commonest type, do not die of it. In one case series of people with non-metastatic papillary thyroid cancer, mortality from the cancer was 6 percent. Follicular cancer generally occurs in older people, follows a more aggressive course, and is more often linked to distant spread and higher mortality.

Call 911 (or your local emergency number) if you cannot breathe properly, if your breathing becomes noisy or whistling at rest, or if your throat or neck swells rapidly. A nodule that narrows the airway is an emergency, not something to raise at the next scan appointment.

Get seen sooner, rather than waiting for the scheduled scan, if:

• A nodule enlarges noticeably over weeks rather than months.
• Your voice becomes hoarse and stays hoarse for more than 2 weeks.
• Swallowing solids becomes difficult, or you choke lying flat.
• You feel short of breath on mild exertion, or when lying down.
• The lump becomes hard and fixed, or new firm neck lumps appear.

What Does TI-RADS Mean?, What Does Bethesda Category Mean on a Thyroid Biopsy?, Thyroid Cancer, and Biopsy.

• https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Reporting-and-Data-Systems/TI-RADS
• https://www.ncbi.nlm.nih.gov/books/NBK535422/
• https://www.cancer.gov/types/thyroid/patient/thyroid-treatment-pdq